PharmaACE Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • PharmaACE's estimated annual revenue is currently $130.7M per year.(i)
  • PharmaACE's estimated revenue per employee is $201,000

Employee Data

  • PharmaACE has 650 Employees.(i)
  • PharmaACE grew their employee count by 9% last year.

PharmaACE's People

NameTitleEmail/Phone
1
Head Technology - Business IntelligenceReveal Email/Phone
2
CTO PharmaACE & Managing Director PharmaACE GmbHReveal Email/Phone
3
Data ScientistReveal Email/Phone
4
Data ScientistReveal Email/Phone
5
Senior Project ManagerReveal Email/Phone
6
Senior Project ManagerReveal Email/Phone
7
Project ManagerReveal Email/Phone
8
Engagement ManagerReveal Email/Phone
9
Cluster ManagerReveal Email/Phone
10
Project Manager - Advanced AnalyticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is PharmaACE?

PharmaACE Analytics is an US-headquartered life sciences focused company that provides analytic solutions for the efficient commercialization of pharmaceutical products. The company has been employing professionals from top education institutes and individuals with excellent experience in the Analytics domain. Our services are designed to provide clients with business critical research and insights that enables them to make informed decisions related to their sales and marketing initiatives. Specialties: Forecasting, Competitive Intelligence, Market Access, Key Opinion Leader Analytics, Market Assessment, Business Analytics, Social Media Monitoring and Analysis

keywords:N/A

N/A

Total Funding

650

Number of Employees

$130.7M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$135M742-1%N/A
#2
$188.2M7473%N/A
#3
$193.3M76724%N/A
#4
$133.2M793-1%N/A
#5
$115.1M8066%N/A